Al-Dawaa Medical Services Company (TADAWUL:4163)

Market Cap	6.27B
Revenue (ttm)	6.59B
Net Income (ttm)	379.95M
Shares Out	85.00M
EPS (ttm)	4.47
PE Ratio	16.50
Forward PE	14.84
Dividend	1.89 (2.57%)
Ex-Dividend Date	May 21, 2025

Volume	15,817
Average Volume	42,254
Open	73.45
Previous Close	73.45
Day's Range	72.35 - 74.00
52-Week Range	65.80 - 98.20
Beta	0.08
RSI	33.29
Earnings Date	Jul 31, 2025

About TADAWUL:4163

Al-Dawaa Medical Services Company, together with its subsidiaries, primarily operates as a pharmaceutical retail company in the Kingdom of Saudi Arabia. It operates through three segments: Retail, Wholesale, and Logistics. The company offers medicines, perfumes, cosmetics, beauty tools and products, and other pharmaceutical products. It is also involved in pharmacy activities, pharmaceutical warehousing activities, retailing of medical and other equipment, land transport of goods, managing and renting self-storage stores, and provision of marke...

• Industry: Medical - Pharmaceuticals
• Sector: Healthcare
• Founded: 1993
• Country: Saudi Arabia
• Stock Exchange: Saudi Stock Exchange
• Ticker Symbol: 4163

Financial Performance

In 2024, TADAWUL:4163's revenue was 6.45 billion, an increase of 12.36% compared to the previous year's 5.74 billion. Earnings were 370.11 million, an increase of 12.42%.